Patent intelligence · EP
EP 1381397
STABILISIERUNG VON RADIOPHARMAZEUTISCHEN ZUSAMMENSETZUNGEN MIT EINEM HYDROPHILEN THIOETHER ODER EINEM HYDROPHILEN 6-HYDROXY-CHROMAN
STABILISIERUNG VON RADIOPHARMAZEUTISCHEN ZUSAMMENSETZUNGEN MIT EINEM HYDROPHILEN THIOETHER ODER EINEM HYDROPHILEN 6-HYDROXY-CHROMAN
Patent details — EP 1381397
- Jurisdiction
- EP
- Status
- expired
- Grant date
- Jan 21, 2004
- Expiration
- Jan 16, 2024
- Applicant
- DIATIDE INC [US]
- CPC classes
- A61K 31/ 56 A I, A61K 31/ 683 A I, A61K 31/ 685 A I, A61K 31/ 688 A I
Quick answer
EP 1381397 (STABILISIERUNG VON RADIOPHARMAZEUTISCHEN ZUSAMMENSETZUNGEN MIT EINEM HYDROPHILEN THIOETHER ODER EINEM HYDROPHILEN 6-HYDROXY-CHROMAN) is held by DIATIDE INC [US]. Status: expired. Granted Jan 21, 2004. Expires Jan 16, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- DIATIDE INC [US]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 56 A I, A61K 31/ 683 A I, A61K 31/ 685 A I, A61K 31/ 688 A I, A61K 31/ 702 A I, A61K 31/ 7004 A I
More from DIATIDE INC [US]
Related pharmaceutical patents in our USPTO index.
-
GB 2467012
Lanthanide (III) ion complexing compounds, luminescent lanthanide (III) ion complexes and use thereof as fluorescent labels
granted -
EP 1913959
Radioaktive Metallkomplexe enthaltend eine Tridentat-Komplex-Sequenz
granted -
US 7238340
Monoamine, diamide, thiol-containing metal chelating agents
granted -
DE 69534943
TECHNETIUM-99M MARKIERTE PEPTIDE ZUR BILDFORMUNG
granted -
DK 0759786
Somatostatinbindende peptidmetal-chelatkonjugater
granted -
US 2005207973
Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy chromans
expired -
US 2005180918
Stabilization of radiopharmaceutical compositions using hydrophilic thioethers
expired
Frequently asked questions
What is US patent 1381397?
EP 1381397 (STABILISIERUNG VON RADIOPHARMAZEUTISCHEN ZUSAMMENSETZUNGEN MIT EINEM HYDROPHILEN THIOETHER ODER EINEM HYDROPHILEN 6-HYDROXY-CHROMAN) is held by DIATIDE INC [US]. Status: expired. Granted Jan 21, 2004. Expires Jan 16, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns EP 1381397?
DIATIDE INC [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 18 pharmaceutical patents for this assignee.
When does EP 1381397 expire?
Our index shows an expiration date of Jan 16, 2024 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.